CLASSYS reported that its operating profit for the first quarter of this year reached 38.8 billion won, an increase of 46.3% compared to the same period last year. During the same period, sales rose 53.06% year-on-year to 77.1 billion won.
The company attributed the growth in performance to the early completion of integration work following the merger with Eruda, which enabled rapid synergy effects. CLASSYS has a strong dealer network in over 80 countries worldwide and serves over 18,000 medical professionals as customers. In the second half of the year, the company is preparing to launch next-generation microneedle products.
As beauty influencers overseas have increased their content sharing experiences related to beauty treatments, awareness of aesthetic medical procedures has rapidly spread abroad, which has also driven CLASSYS's export growth. The company is experiencing strong growth in its main export countries, including Brazil, Thailand, and Japan, and the sales of 'Everesse' (known domestically as Voluneur), launched in the U.S. in October last year, also contributed. Sales performance of 'Shrinks Universe', which has a high satisfaction rate globally, is also on the rise.
A CLASSYS official noted, "The first quarter of this year recorded strong performance, thanks to high customer satisfaction and the spread of treatment awareness, and we will continue to implement aggressive growth strategies to achieve our quarterly goals. We aim to lead the market as the world's No. 1 beauty medical corporation with energy-based recurring platform (EBRP) by enhancing our research and development, licensing, and brand strengthening for sustainable long-term growth, while holding both performance and momentum."